AVROBIO

AVROBIO

AVROBIO

Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
Raised
$184.7M
Follow us
Alexa global traffic share
Twitter followers
21 Jun 2018
01 Feb 2018
$60,000,000
Venture capital (Series B)

Avrobio Raises $60M in Series B Financing

FinSMEs
+2